Bid Publish Date
25-Jun-2025, 7:39 pm
Bid End Date
16-Jul-2025, 8:00 pm
EMD
₹590
Location
Progress
RAQuantity
417141
Category
Inj Human Insulin Analogue Glargine monocomponent R to DNA
Bid Type
Two Packet Bid
A tender has been published for Indian Army Atenolol 50mg plus Amlodipine 5 mg Tab, Clonidine 100 mcg Tab, Hydrochlorothiazide 25mg, Bisoprolol 5 in JABALPUR, MADHYA PRADESH. Quantity: 417141 by. Submission Deadline: 16-07-2025 20: 00: 00. Check eligibility and apply.
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Atenolol 50mg plus Amlodipine 5 mg Tab | Atenolol 50mg plus Amlodipine 5 mg Tab | 1,800 | no | dglpproc2023 | 30 |
| 2 | Clonidine 100 mcg Tab | Clonidine 100 mcg Tab | 1,500 | no | dglpproc2023 | 30 |
| 3 | Hydrochlorothiazide 25mg | Hydrochlorothiazide 25mg | 13,000 | tab | dglpproc2023 | 30 |
| 4 | Bisoprolol 5 mg Tab | Bisoprolol 5 mg Tab | 4,000 | no | dglpproc2023 | 30 |
| 5 | Amlodipine 10 mg Tab | Amlodipine 10 mg Tab | 30,000 | no | dglpproc2023 | 30 |
| 6 | Antiseptic mouth wash containing Sodium fluoride | Antiseptic mouth wash containing Sodium fluoride | 2,000 | bott | dglpproc2023 | 30 |
| 7 | Anticaries Fluoride Rinse Mouth wash with sodium fluoride | Anticaries Fluoride Rinse Mouth wash with sodium fluoride | 900 | bott | dglpproc2023 | 30 |
| 8 | Clove Oil bottle of 50ml | Clove Oil bottle of 50ml | 30 | bott | dglpproc2023 | 30 |
| 9 | Desensitising paste Stannous Fluoride per Potassium Nitrate | Desensitising paste Stannous Fluoride per Potassium Nitrate | 60 | tube | dglpproc2023 | 30 |
| 10 | Anticaries Fluoride Gel containing sodium fluoride per Stannous | Anticaries Fluoride Gel containing sodium fluoride per Stannous | 60 | bott per tube | dglpproc2023 | 30 |
| 11 | Triamcinolone Acetonide 0.1 percent for oral use tube of 5 gm | Triamcinolone Acetonide 0.1 percent for oral use tube of 5 gm | 480 | tube | dglpproc2023 | 30 |
| 12 | L to Ornithine L to Aspartate powder 5gm | L to Ornithine L to Aspartate powder 5gm | 300 | scht | dglpproc2023 | 30 |
| 13 | Bacillus Clausii 2 billion spores per 5 ml | Bacillus Clausii 2 billion spores per 5 ml | 1,500 | bott | dglpproc2023 | 30 |
| 14 | Octreotide 0.1 mg per ml Inj | Octreotide 0.1 mg per ml Inj | 24 | amp | dglpproc2023 | 30 |
| 15 | Mesalamine Suppository 500 mg | Mesalamine Suppository 500 mg | 125 | no | dglpproc2023 | 30 |
| 16 | Pancreatic Enzyme supplement with a Lipase content | Pancreatic Enzyme supplement with a Lipase content | 7,500 | no | dglpproc2023 | 30 |
| 17 | Antispasmodic Tab containing Mefenamic Acid 250 mg and | Antispasmodic Tab containing Mefenamic Acid 250 mg and | 6,300 | no | dglpproc2023 | 30 |
| 18 | Tab Levosulpiride 25 mg | Tab Levosulpiride 25 mg | 1,200 | no | dglpproc2023 | 30 |
| 19 | Tab Entacavir 0.5 mg | Tab Entacavir 0.5 mg | 2,000 | no | dglpproc2023 | 30 |
| 20 | Oint Diltiazem 2 percent tube of 30 gm | Oint Diltiazem 2 percent tube of 30 gm | 500 | tube | dglpproc2023 | 30 |
| 21 | Trypsin with chymotrypsin Tab | Trypsin with chymotrypsin Tab | 35,000 | no | dglpproc2023 | 30 |
| 22 | Sodium bicarbonate 0.5 gm Tab | Sodium bicarbonate 0.5 gm Tab | 7,000 | no | dglpproc2023 | 30 |
| 23 | Lactic Acid Bacillus Sachet | Lactic Acid Bacillus Sachet | 6,000 | sch | dglpproc2023 | 30 |
| 24 | Metoclopramide 10 mg Tab | Metoclopramide 10 mg Tab | 10,500 | no | dglpproc2023 | 30 |
| 25 | Metoclopramide syrup 5 mg per 5 ml bott of 30 ml | Metoclopramide syrup 5 mg per 5 ml bott of 30 ml | 50 | bott | dglpproc2023 | 30 |
| 26 | Dicyclomine HCl 20 mg Inj | Dicyclomine HCl 20 mg Inj | 700 | amp | dglpproc2023 | 30 |
| 27 | Drotaverine HCl 20 mg per ml Inj | Drotaverine HCl 20 mg per ml Inj | 660 | vial | dglpproc2023 | 30 |
| 28 | Tab per Cap Dicyclomine 10mg | Tab per Cap Dicyclomine 10mg | 3,300 | no | dglpproc2023 | 30 |
| 29 | Hyoscine Bromide Inj 20 mg per ml 1 ml Inj | Hyoscine Bromide Inj 20 mg per ml 1 ml Inj | 740 | vial | dglpproc2023 | 30 |
| 30 | Isapgol per Ispaghula husk 3.5 gm | Isapgol per Ispaghula husk 3.5 gm | 40,000 | scht | dglpproc2023 | 30 |
| 31 | Loperamide 2 mg Tab | Loperamide 2 mg Tab | 1,200 | no | dglpproc2023 | 30 |
| 32 | Oestrogen Cream Concentration 0.06 percent to 0.1 percent | Oestrogen Cream Concentration 0.06 percent to 0.1 percent | 60 | tube per jar | dglpproc2023 | 30 |
| 33 | Dinoprostone Gel 0.5 mg in 3 gm per 2.5 ml gel per Syringe | Dinoprostone Gel 0.5 mg in 3 gm per 2.5 ml gel per Syringe | 300 | no | dglpproc2023 | 30 |
| 34 | Medroxy progesterone 10 mg Tab | Medroxy progesterone 10 mg Tab | 6,000 | no | dglpproc2023 | 30 |
| 35 | Nor to Ethisterone 5 mg Tab | Nor to Ethisterone 5 mg Tab | 18,600 | no | dglpproc2023 | 30 |
| 36 | Gliclazide MR 30 mg Tab | Gliclazide MR 30 mg Tab | 9,300 | no | dglpproc2023 | 30 |
| 37 | Tab Vildagliptin 50 mg | Tab Vildagliptin 50 mg | 20,000 | no | dglpproc2023 | 30 |
| 38 | Pioglitazone Hydrochloride 15 mg Tab | Pioglitazone Hydrochloride 15 mg Tab | 1,500 | no | dglpproc2023 | 30 |
| 39 | Carbimazole 5 mg Tab | Carbimazole 5 mg Tab | 4,000 | no | dglpproc2023 | 30 |
| 40 | Tab Thyroxine Sodium 12.5 mcg | Tab Thyroxine Sodium 12.5 mcg | 12,600 | no | dglpproc2023 | 30 |
| 41 | Cap Tacrolimus 1 mg prolonged release | Cap Tacrolimus 1 mg prolonged release | 700 | no | dglpproc2023 | 30 |
| 42 | Tab Solifenacin 5 mg | Tab Solifenacin 5 mg | 1,000 | no | dglpproc2023 | 30 |
| 43 | Cap Tacrolimus 0.25 mg | Cap Tacrolimus 0.25 mg | 700 | no | dglpproc2023 | 30 |
| 44 | Tab Mycophenolate Sodium 180 mg | Tab Mycophenolate Sodium 180 mg | 180 | no | dglpproc2023 | 30 |
| 45 | Tab Mycophenolate Mofetil 750 mg | Tab Mycophenolate Mofetil 750 mg | 180 | no | dglpproc2023 | 30 |
| 46 | Tacrolimus 1 mg Tab | Tacrolimus 1 mg Tab | 600 | no | dglpproc2023 | 30 |
| 47 | Tacrolimus 0.5 mg Cap | Tacrolimus 0.5 mg Cap | 1,000 | no | dglpproc2023 | 30 |
| 48 | Sevelamer 400 mg Tab | Sevelamer 400 mg Tab | 1,200 | no | dglpproc2023 | 30 |
| 49 | Inj Human Insulin Analogue Glargine monocomponent R to DNA | Inj Human Insulin Analogue Glargine monocomponent R to DNA | 1,000 | pen | dglpproc2023 | 30 |
| 50 | Syp Diphenhydramine 10 to 15 mg per 5 ml and Ammonium | Syp Diphenhydramine 10 to 15 mg per 5 ml and Ammonium | 4,000 | bott | dglpproc2023 | 30 |
| 51 | Beclomethasone Dipropionate nasal spray 50 mcg per dose | Beclomethasone Dipropionate nasal spray 50 mcg per dose | 420 | bott | dglpproc2023 | 30 |
| 52 | Betahistine Dihydrochloride 8 mg Tab | Betahistine Dihydrochloride 8 mg Tab | 3,500 | no | dglpproc2023 | 30 |
| 53 | Cinnarizine 25 mg Tab | Cinnarizine 25 mg Tab | 2,000 | no | dglpproc2023 | 30 |
| 54 | Prochlorperazine Maleate 5 mg Tab | Prochlorperazine Maleate 5 mg Tab | 1,200 | no | dglpproc2023 | 30 |
| 55 | Sodium Cromoglycate Nasal Spray 2 percent w per v bottle of | Sodium Cromoglycate Nasal Spray 2 percent w per v bottle of | 120 | bott | dglpproc2023 | 30 |
| 56 | Salmeterol 25 mcg plus Fluticasone 125 mg MDI 120 Counter | Salmeterol 25 mcg plus Fluticasone 125 mg MDI 120 Counter | 1,200 | no | dglpproc2023 | 30 |
| 57 | Midazolam nasal spray 0.5 mg per spray 5 ml bottle | Midazolam nasal spray 0.5 mg per spray 5 ml bottle | 150 | bott | dglpproc2023 | 30 |
| 58 | Frusemide 10 mg per ml 30 ml Syp | Frusemide 10 mg per ml 30 ml Syp | 20 | bott | dglpproc2023 | 30 |
| 59 | Cyproheptadine HCl 2 mg per 5 ml bott of 100 ml | Cyproheptadine HCl 2 mg per 5 ml bott of 100 ml | 300 | bott | dglpproc2023 | 30 |
| 60 | Syp Dicyclomine drops of 15 ml | Syp Dicyclomine drops of 15 ml | 600 | bott | dglpproc2023 | 30 |
| 61 | Isoniazid syp 100 mg per 5 ml 120 ml bott | Isoniazid syp 100 mg per 5 ml 120 ml bott | 12 | bott | dglpproc2023 | 30 |
| 62 | Metronidazole susp 200 mg per 5 ml bott of 60 ml | Metronidazole susp 200 mg per 5 ml bott of 60 ml | 500 | bott | dglpproc2023 | 30 |
| 63 | Norflox Syp 100 mg per 5 ml bott of 30 ml | Norflox Syp 100 mg per 5 ml bott of 30 ml | 500 | bott | dglpproc2023 | 30 |
| 64 | Ondansetron Syp 2 mg per 5 ml in bott of 30 ml | Ondansetron Syp 2 mg per 5 ml in bott of 30 ml | 1,000 | bott | dglpproc2023 | 30 |
| 65 | Iron drops Paediatric. Each ml contains Ferrous Fumarate | Iron drops Paediatric. Each ml contains Ferrous Fumarate | 2,500 | bott | dglpproc2023 | 30 |
| 66 | Prednisolone Syp 5 mg per 5ml in bott of 30 ml | Prednisolone Syp 5 mg per 5ml in bott of 30 ml | 300 | bott | dglpproc2023 | 30 |
| 67 | Roxithromycin 50mg per 5 ml Syp 30 ml bott | Roxithromycin 50mg per 5 ml Syp 30 ml bott | 60 | bott | dglpproc2023 | 30 |
| 68 | Levo to Salbutamol syp 1 mg per 5 ml 100 ml bott | Levo to Salbutamol syp 1 mg per 5 ml 100 ml bott | 450 | bott | dglpproc2023 | 30 |
| 69 | Syrup Calcium Phosphate 80 mg per 5 ml 200 ml bottle | Syrup Calcium Phosphate 80 mg per 5 ml 200 ml bottle | 900 | no | dglpproc2023 | 30 |
| 70 | Clonazepam 0.5 mg Tab | Clonazepam 0.5 mg Tab | 11,100 | no | dglpproc2023 | 30 |
| 71 | Duloxetine 20 mg Tab | Duloxetine 20 mg Tab | 5,100 | no | dglpproc2023 | 30 |
| 72 | Fluoxetine HCl 20 mg Cap | Fluoxetine HCl 20 mg Cap | 12,900 | no | dglpproc2023 | 30 |
| 73 | Fluvoxamine 50 mg Cap | Fluvoxamine 50 mg Cap | 7,200 | no | dglpproc2023 | 30 |
| 74 | Haloperidol decanoate 50 mg per ml Inj in 1ml amp | Haloperidol decanoate 50 mg per ml Inj in 1ml amp | 150 | amp | dglpproc2023 | 30 |
| 75 | Haloperidol 5 mg per ml Inj | Haloperidol 5 mg per ml Inj | 600 | amp | dglpproc2023 | 30 |
| 76 | Haloperidol 5 mg Tab | Haloperidol 5 mg Tab | 2,400 | no | dglpproc2023 | 30 |
| 77 | Imipramine 25 mg Tab | Imipramine 25 mg Tab | 2,100 | no | dglpproc2023 | 30 |
| 78 | Lorazepam 1 mg Tab | Lorazepam 1 mg Tab | 12,900 | no | dglpproc2023 | 30 |
| 79 | Memantine 10 mg Tab | Memantine 10 mg Tab | 2,400 | no | dglpproc2023 | 30 |
| 80 | Lithium Carbonate 300 mg Cap per Tab | Lithium Carbonate 300 mg Cap per Tab | 9,900 | no | dglpproc2023 | 30 |
| 81 | Aripiprazole 10 mg Tab | Aripiprazole 10 mg Tab | 9,600 | no | dglpproc2023 | 30 |
| 82 | Atomoxetine 10 mg Tab | Atomoxetine 10 mg Tab | 3,900 | no | dglpproc2023 | 30 |
| 83 | Olanzapine 10 mg Tab | Olanzapine 10 mg Tab | 4,500 | no | dglpproc2023 | 30 |
| 84 | Olanzapine 5 mg Tab | Olanzapine 5 mg Tab | 10,500 | no | dglpproc2023 | 30 |
| 85 | Zolpidem 10 mg Tab | Zolpidem 10 mg Tab | 3,900 | no | dglpproc2023 | 30 |
| 86 | Tianeptine 12.5 mg Tab | Tianeptine 12.5 mg Tab | 900 | no | dglpproc2023 | 30 |
| 87 | Paroxetine XR 12.5 Tab | Paroxetine XR 12.5 Tab | 10,800 | no | dglpproc2023 | 30 |
| 88 | Etophylline BP 84.7 mg and Theophylline IP 25.3 mg per ml | Etophylline BP 84.7 mg and Theophylline IP 25.3 mg per ml | 100 | amp per vial | dglpproc2023 | 30 |
| 89 | Beclomethasone Dipropionate 50 mcg and Levosalbutamol | Beclomethasone Dipropionate 50 mcg and Levosalbutamol | 360 | no | dglpproc2023 | 30 |
| 90 | Tiotropium Bromide 18 mcg and Formoterol 12 mcg dry | Tiotropium Bromide 18 mcg and Formoterol 12 mcg dry | 250 | no | dglpproc2023 | 30 |
| 91 | Cough expectorant syp 5 ml containing Diphenhydramine | Cough expectorant syp 5 ml containing Diphenhydramine | 7,000 | bott | dglpproc2023 | 30 |
| 92 | Cough sedative syp each 5 ml containing Chlorpheniramine | Cough sedative syp each 5 ml containing Chlorpheniramine | 7,000 | bott | dglpproc2023 | 30 |
| 93 | Solifenacin 10 mg Tab | Solifenacin 10 mg Tab | 300 | no | dglpproc2023 | 30 |
| 94 | Alfuzosin 10 mg Tab | Alfuzosin 10 mg Tab | 1,200 | no | dglpproc2023 | 30 |
| 95 | Silodosin 4 mg Tab | Silodosin 4 mg Tab | 800 | no | dglpproc2023 | 30 |
| 96 | Sildenafil Citrate 50 mg Tab | Sildenafil Citrate 50 mg Tab | 800 | no | dglpproc2023 | 30 |
| 97 | Vit B 12 500 mcg per ml Inj | Vit B 12 500 mcg per ml Inj | 2,250 | amp | dglpproc2023 | 30 |
| 98 | Iron Syp Paediatric each 5 ml containing elemental Iron | Iron Syp Paediatric each 5 ml containing elemental Iron | 1,200 | no | dglpproc2023 | 30 |
| 99 | Multi Vit Inj IV 10 ml with minimum constituents having | Multi Vit Inj IV 10 ml with minimum constituents having | 1,300 | amp | dglpproc2023 | 30 |
| 100 | Multivitamin drops with constituents having Vit A Vit B1 B2 | Multivitamin drops with constituents having Vit A Vit B1 B2 | 1,800 | bott | dglpproc2023 | 30 |
| 101 | Inj Dulaglutide 1.5 mg per ml 0.5 ml PFS | Inj Dulaglutide 1.5 mg per ml 0.5 ml PFS | 150 | pfs | dglpproc2023 | 30 |
| 102 | Digoxin 0.25 mg Tab | Digoxin 0.25 mg Tab | 1,200 | no | dglpproc2023 | 30 |
| 103 | Dapagliflozin 5 mg Tab | Dapagliflozin 5 mg Tab | 3,500 | no | dglpproc2023 | 30 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Start
05-Nov-2025, 11:00 am
End
06-Nov-2025, 1:00 pm
Duration: 26 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 15-07-2025 17:56:29 | Evaluated |
| 2 | ********** Under PMA | - | 16-07-2025 18:11:11 | Evaluated |
| 3 | ********** Under PMA | - | 15-07-2025 10:32:18 | Evaluated |
| 4 | ********** Under PMA | - | 15-07-2025 07:21:53 | Evaluated |
| 5 | ********** Under PMA | - | 15-07-2025 19:55:32 | Evaluated |
| 6 | ********** Under PMA | - | 16-07-2025 14:49:32 | Evaluated |
| 7 | ********** Under PMA | - | 15-07-2025 20:09:56 | Evaluated |
| 8 | ********** Under PMA | - | 09-07-2025 14:09:52 | Evaluated |
| 9 | ********** Under PMA | - | 16-07-2025 11:53:48 | Evaluated |
| 10 | ********** Under PMA | - | 15-07-2025 22:44:57 | Evaluated |
| 11 | ********** Under PMA | - | 16-07-2025 14:07:28 | Evaluated |
| 12 | ********** Under PMA | - | 15-07-2025 19:44:33 | Evaluated |
| 13 | ********** Under PMA | - | 16-07-2025 14:38:28 | Evaluated |
| 14 | ********** Under PMA | - | 16-07-2025 18:38:20 | Evaluated |
| 15 | ********** Under PMA | - | 16-07-2025 14:13:32 | Evaluated |
| 16 | ********** Under PMA | - | 12-07-2025 19:51:41 | Evaluated |
| 17 | ********** Under PMA | - | 15-07-2025 12:57:39 | Evaluated |
| 18 | ********** Under PMA | - | 06-07-2025 12:49:21 | Evaluated |
| 19 | ********** Under PMA | - | 16-07-2025 17:05:51 | Evaluated |
| 20 | ********** Under PMA | - | 16-07-2025 17:43:17 | Evaluated |
| 21 | ********** Under PMA | - | 15-07-2025 11:29:41 | Evaluated |
| 22 | ********** Under PMA | - | 05-07-2025 10:34:38 | Evaluated |
| 23 | ********** Under PMA | - | 16-07-2025 17:28:25 | Evaluated |
| 24 | ********** Under PMA | - | 16-07-2025 18:53:04 | Evaluated |
| 25 | ********** Under PMA | - | 15-07-2025 18:55:52 | Evaluated |
| 26 | ********** Under PMA | - | 16-07-2025 16:03:42 | Evaluated |
Key insights about MADHYA PRADESH tender market
The eligibility requirements include that bidders must be a registered entity who can supply the mentioned medications. They must also present relevant certifications for pharmaceutical products and a proven history of handling similar projects effectively.
Bidders are required to provide certificates affirming adherence to necessary quality standards and industry norms associated with pharmaceutical supply, along with any specific documents that prove compliance with established regulations.
Interested bidders need to follow the registration directives detailed in the tender documentation, ensuring they complete all necessary prerequisites before bid submission. It is important to address any technical specifications needed beforehand.
The tender outlines specific payment terms, which include details on the payment schedule following the successful delivery of goods. Bidders must clarify these terms in their submissions to ensure there are no discrepancies post-awarding.
This tender provides special provisions aimed at promoting Micro, Small, and Medium Enterprises (MSEs), including adjusted eligibility criteria and potential support measures tailored to enhance competitiveness and encourage market participation from these businesses.
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS